Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 3Ovarian Neoplasms 3Carcinoma, Hepatocellular 3Stomatitis 2Stomach Neoplasms 2Ototoxicity 2Neurofibromatosis 1 2Liver Neoplasms 2Hearing Loss 2Head and Neck Neoplasms 2Weight Loss 1Ulcer 1Tongue Neoplasms 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Radiation-Induced Mucositis 1Radiation Pneumonitis 1Pseudomyxoma Peritonei 1Primary Myelofibrosis 1Primary Graft Dysfunction 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma 1

Interventions

Cognitive Training 2Tobacco Use Cessation Devices 1Sodium Chloride 1Saline Solution 1Palliative Care 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Electroacupuncture 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Ashwagandha 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-Related Cognitive Impairment × Acetylcysteine × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡